Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study-Reference-Cited by-同舟云学术

Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study

Published:2018-01-03 Issue:4 Volume:37 Page:745-754
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Popovic Natasa,Korac Milos,Nesic Zorica,Milosevic Branko,Urosevic Aleksandar,Jevtovic Djordje,Mitrovic Nikola,Markovic Aleksandar,Jordovic Jelena,Katanic Natasa,Barac Aleksandra,Milosevic Ivana^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s10096-017-3169-3/fulltext.html

Reference36 articles.

1. De Pestel DD, Aronoff DM (2013) Epidemiology of Clostridium difficile infection. J Pharm Pract 26(5):464–475

2. Bauer MP, Notermans DW, van Benthem BH et al (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63–73

3. Kelly CP (2012) Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 18(Suppl 6):21–27

4. Cornely OA, Miller MA, Louie TJ et al (2012) Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis 55(Suppl 2):S154–S161

5. Penziner S, Dubrovskaya Y, Press R et al (2015) Fidaxomicin therapy in critically ill patients with Clostridium difficile infection. Antimicrob Agents Chemother 59(3):1776–1781

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fighting against Clostridioides difficile infection: Current medications;International Journal of Antimicrobial Agents;2024-07

2. Infections in Hematopoietic Stem Cell Transplant Recipients in India – Think Global, Act Local;Journal of Clinical Infectious Disease Society;2024-07

3. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options;Clinical Microbiology Reviews;2024-06-13

4. Oral teicoplanin administration suppresses recurrence of Clostridioides difficile infection: Proof of concept;Anaerobe;2023-12

5. Clostridium difficile in Oncology Patients—Review of Diagnosis and Management in the Indian Setting;Indian Journal of Medical and Paediatric Oncology;2023-03-01